Acrivon Therapeutics, Inc. Share Price

NASDAQ: ACRV

Small Cap

$1.52

(+0.33%)

as on September 16, 2025 at 1:29 am IST

$₹

Acrivon Therapeutics, Inc. Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$1.47
Day's Price Range
$1.56
$1.52
3.29%
Downside
2.63%
Upside
52 Week's Low
52 Week's High
$1.05
52-Week Price Range
$10
$1.52
30.92%
Downside
557.89%
Upside

Acrivon Therapeutics, Inc. share price movements today

Previous Close: $1.52
Open: $1.51
Volume: 2.2M
Day's Low - High: $1.47 - $1.56
52 Week Low - High: $1.05 - $10

Acrivon Therapeutics, Inc. Historical Returns

1 Month Return: + 12.59 %
3 Month Return: + 26.67 %
1 Year Return: -82.94 %
3 Year Return: 0 %
5 Year Return: 0 %

Acrivon Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Acrivon Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$47.8M

EPS (TTM)

-2.2271

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-93.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Acrivon Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Acrivon Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Acrivon Therapeutics, Inc.	BUY	$47.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Acrivon Therapeutics, Inc. Stock including INR - Dollar returns

The Acrivon Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Acrivon Therapeutics, Inc. investment value today

Current value as on today

₹22,045

Returns

₹77,955

(-77.96%)

Returns from Acrivon Therapeutics, Inc. Stock

₹82,941 (-82.94%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Acrivon Therapeutics, Inc. Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Acrivon Therapeutics, Inc.. Average target price of $11.17

Acrivon Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Acrivon Therapeutics, Inc..

What analysts predicted

86.39%UPSIDE

Target Price

$11.17

Current Price

$1.52

Analyzed by

16 Analysts

Target

$11.17

Acrivon Therapeutics, Inc. target price $11.17, a slight upside of 86.39% compared to current price of $1.52. According to 16 analysts rating.

Acrivon Therapeutics, Inc. Stock's Interest Amongst Investors

Search interest for Acrivon Therapeutics, Inc. Stock has increased by 127% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:127% versus previous 30 day period

Acrivon Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	-	-	-	0	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-14	-15	-16	-21	-17	-21	-25	-24	-21	-22
EBITDA	-14	-15	-14	-20	-17	-12	-24	-24	-19	-22
Interest Expense	1	-	-	1	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-12	-13	-14	-19	-16	-18	-22	-22	-19	-21
Income Tax Expense	-1	0	0	1	0	-	-	0	-	-
Net Income	-11	-13	-14	-19	-16	-18	-22	-22	-19	-21
Net Profit Margin	0.00%	0.00%	0.00%	-1021.87%	0.00%	0.00%	0.00%	-2692.33%	0.00%	0.00%

Acrivon Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-
Gross Profit	0	0	-1	0	-1
Operating Income	-3	-16	-32	-67	-89
EBITDA	-5	-15	-32	-59	-79
Interest Expense	-	0	1	-	-
Depreciation	0	0	0	0	1
Income Before Tax	-5	-16	-31	-60	-80
Income Tax Expense	0	0	-1	0	-
Net Income	-5	-16	-29	-60	-80
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Acrivon Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-13	-14	-19	-16	-18	-22	-22	-19	-21
Operating Cash Flow	-9	-9	-12	-17	-13	-17	-17	-19	-16
Investing Cash Flow	19	1	20	5	-88	16	14	19	19
Financing Cash Flow	0	0	-2	0	123	-1	0	0	0
Change in Cash	10	-8	6	-11	21	-2	-3	0	2

Acrivon Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-16	-31	-60	-80
Operating Cash Flow	-13	-30	-42	-65
Investing Cash Flow	0	-141	50	-51
Financing Cash Flow	112	101	-1	121
Change in Cash	98	-70	6	3

Global Institutional Holdings in Acrivon Therapeutics, Inc.

Funds	Holdings
RA Capital Management, LLC	26.6%
Perceptive Advisors LLC	17.1%
Sands Capital Ventures, LLC	6.77%
Citadel Advisors Llc	6.05%
BlackRock Inc	2.99%

See all

Insights on Acrivon Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 152.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ACRV stock has moved down by -8.5%

About Acrivon Therapeutics, Inc.

acrivon therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach. our technology platform is based on integrating drug-regulated, global proteomics with focused intact tissue digital imaging to develop drug-tailored biomarker signatures for prospective patient responder identification. the foundational science is based on proven, pathway-based methods linking active disease-driving mechanisms with the drug mechanism-of-action, to precisely match the therapy with patients who will benefit. our method is applicable across drug modalities

Organisation	Acrivon Therapeutics, Inc.
Headquarters	480 Arsenal Way, Watertown, MA, United States, 02472
Industry	Healthcare
CEO	Dr. Peter Blume-Jensen M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Acrivon Therapeutics, Inc.

Name	Title
Mr. Joon Jung Ph.D.	VP & Head of Data Science
Ms. Kristina Masson M.B.A., Ph.D.	Co-Founder, Executive VP of Business Operations, Site Head, Treasurer & Director
Ms. Katharine Peterson CPA	Vice President of Finance & Accounting
Dr. Erick Gamelin M.D., Ph.D.	Chief Development Officer
Mr. Bruce Close	Vice President of Quality & Compliance
Ms. Mary-Alice Miller J.D.	Chief Legal Officer & Corporate Secretary
Dr. Jesper V. Olsen Ph.D.	Academic Co-Founder, Head of Phosphoproteomics & Member of Scientific Advisory Board
Dr. Peter Blume-Jensen M.D., Ph.D.	Co-Founder, Chairman of the Board, CEO, President & Acting Chief Scientific Officer
Dr. Eric J. Devroe Ph.D.	Chief Operating Officer
Dr. Adam D. Levy M.B.A., Ph.D.	CFO & Principal Financial Officer

FAQs

What is Acrivon Therapeutics, Inc. share price today?

Acrivon Therapeutics, Inc. share price today is $1.52 as on September 16, 2025 at 1:29 am IST at the close of the market. Acrivon Therapeutics, Inc. share today touched a day high of $1.56 and a low of $1.47.

What is the 52 week high and 52 week low for Acrivon Therapeutics, Inc. share?

Acrivon Therapeutics, Inc. share touched a 52 week high of $10 on September 16, 2024 and a 52 week low of $1.05 on June 2, 2025. Acrivon Therapeutics, Inc. stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $1.52,which is 84.80% down from its 52 week high and 44.76% up from its 52 week low.

What is Acrivon Therapeutics, Inc.'s market capitalisation today?

Acrivon Therapeutics, Inc. market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Acrivon Therapeutics, Inc. Stock (ACRV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Acrivon Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acrivon Therapeutics, Inc. Shares that will get you 0.9868 shares as per Acrivon Therapeutics, Inc. share price of $1.52 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Acrivon Therapeutics, Inc. Stock (ACRV) from India?

Indian investors can start investing in Acrivon Therapeutics, Inc. (ACRV) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 12:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Acrivon Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 12:40 pm IST). Based on Acrivon Therapeutics, Inc. share’s latest price of $1.52 as on September 16, 2025 at 1:29 am IST, you will get 6.5789 shares of Acrivon Therapeutics, Inc.. Learn more about fractional shares .